neobookRx
DrugsLevel 4 LocalisationN/AOTHEML

Bismuth compounds: Bismuth oxide, Bismuth subgallate, Bismuth subcarbonate

Benzene derivativeNot available as a single agent preparation

Cautions

Contraindications 

  • Hypersensitivity to the active ingredient or any of its excipients
  • Children

Cautions 

  • Pregnancy
  • Breastfeeding
  • Renal impairment
  • Hepatic impairment
  • Rectal bleeding
  • Bloody stool

Special populations

Pregnancy

  • Caution
  • Should only be used when potential benefit to the mother outweighs foetal risk
  • There is no formal study on the risk in pregnancy, and there is no epidemiological evidence of adverse effect

Breastfeeding

  • Caution
  • No data available to determine risk to breastfeeding infants

Renal Impairment

Hepatic Impairment

Elderly

Adverse reactions

Central Nervous System Disorders

  • Encephalopathy

Gastrointestinal Disorders

  • Nausea and vomiting
  • Discolouration of mucous membranes

Genitourinary Disorders

  • Renal failure

Hepatobiliary Disorders

  • Liver damage

Skin and Subcutaneous Tissue Disorders

  • Burn
  • Erythema
  • Exfoliation
  • Irritation
  • Pruritus
  • Rash
  • Urticaria

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity

Interactions

No significant interactions

Mechanism of action

Bismuth
Bismuth is weakly astringent, and has possible antiseptic qualities.  This results in a protective effect on mucous membranes and raw surfaces.  Bismuth improves stool consistency and odour through an unclear mechanism of action.

Dosage forms

  • Other

References

1. Pharmacologist: Dr Ahmed Abulfathi 1.1 Lambert JR et al. Aliment Pharmacol Ther 1997; 11 (Suppl. 1): 27-33 1.2 Anusol suppository SmPC 1.3 NIH National library of Medicine 1.4 FDA 21 CFR part 357, docket No. 81N-0064, Federal Register/Vol 47, No.2/Tuesday, January 5, 1982 2. NAPOS The Drug Database for Acute Porphyria: Bismuth; Accessed online 12 Nov 2018 http://www.drugs-porphyria.org/languages/UnitedKingdom/s1.php?l=gbr 3. South African Institute for Drug-Free Sport: Bismuth; Accessed online 12 Nov 2018 [http://www.drugfreesport.org.za/online-medication-check/] 4. U2D: Bismuth subgallate: Drug information; Uptodate; Downloaded online; 12 Nov 2018 https://www.uptodate.com/contents/bismuth-subgallate-drug-information?search=bismuth%20subgallate&source=panel_search_result&selectedTitle=1~33&usage_type=panel&kp_tab=drug_general&display_rank=1#F50990191 *Completed according to specialist input (Dr Ahmed)

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 15456 · updated 7/12/2022